Suicide Ideation, Attempts, and Mortality in Multiple Sclerosis: A Systematic Review and Meta‐Analysis
Brain and Behavior · 2025-09 · 15 (9)
DOI: 10.1002/brb3.70839 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Brain and Behavior, online erschienen am 09.09.2025. Verfasst von Omid Mirmosayyeb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: Multiple Sclerosis, Suicidal Ideation, Suicide, Attempted, Suicide. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Living with multiple sclerosis (MS) means facing significant obstacles in managing the unpredictable nature of this lifelong condition. Studies highlight a concerning connection between the disease and an elevated risk of suicide. In this study, we assessed the prevalence of suicide and suicide mortality risk in people with MS (PwMS).
Methods
A comprehensive and systematic search of Medline, EMBASE, Scopus, and Web of Science databases was conducted. Studies of any design were included if they reported at least one of the following outcomes: (1) the prevalence of suicide ideation, suicide attempts, suicide deaths, and the proportion of suicide deaths among total deaths in MS populations (2) the risk of suicide mortality in PwMS compared to healthy controls.
Results
The systematic review and meta‐analysis included 64 studies across 19 countries, predominantly from Europe and North America, encompassing over 200,000 PwMS. The pooled prevalence of suicide ideation was 22.6% (95% CI: 16.9–28.3). Suicide attempts were reported at 3.4% (95% CI: 1.6–5.2), while suicide mortality was 0.5% (95% CI: 0.3–0.7), accounting for 2.1% (95% CI: 1.5–2.7) of total mortality in PwMS. PwMS had a significantly higher suicide mortality risk compared to healthy controls (standardized mortality ratio [SMR] = 1.49, 95% CI: 1.08–2.05).
Conclusion
This study highlights the elevated suicide mortality risk among PwMS, underscoring the urgent need for integrated mental health care in MS management. Future research should explore the impact of disease‐modifying therapies, protective factors, and standardized risk assessment tools to improve early intervention and reduce suicidal behavior in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Neurology, Isfahan University of Medical Sciences, Isfahan, Iran.
- School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Omid Mirmosayyeb, Aynaz Mohammadi, Mohammad Mohammadi
Zitieren
APA
Mirmosayyeb, O., Khodadadi, H., Mohammadi, A., Abbasi, M., Vaheb, S., Yazdan Panah, M., Mohammadi, M., & Shaygannejad, V. (2025). Suicide Ideation, Attempts, and Mortality in Multiple Sclerosis: A Systematic Review and Meta‐Analysis. Brain and Behavior, 15(9). https://doi.org/10.1002/brb3.70839
Vancouver
Mirmosayyeb O, Khodadadi H, Mohammadi A, Abbasi M, Vaheb S, Yazdan Panah M, et al. Suicide Ideation, Attempts, and Mortality in Multiple Sclerosis: A Systematic Review and Meta‐Analysis. Brain and Behavior. 2025;15(9). doi:10.1002/brb3.70839
BibTeX
@article{Mirmosayyeb2025,
author = {Mirmosayyeb, Omid and Khodadadi, Homa and Mohammadi, Aynaz and Abbasi, Motahareh and Vaheb, Saeed and Yazdan Panah, Mohammad and Mohammadi, Mohammad and Shaygannejad, Vahid},
title = {Suicide Ideation, Attempts, and Mortality in Multiple Sclerosis: A Systematic Review and Meta‐Analysis},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {9},
doi = {10.1002/brb3.70839}
}
EUVIMED